Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Eledon Pharmaceuticals in a report released on Sunday, March 23rd. Lee… [+3005 chars]...
Read moreEledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for Eledon Pharmaceuticals in a note iss… [+3083 chars]...
Read moreEledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Equities researchers at Leerink Partnrs decreased their FY2025 earnings estimates for Eledon Pharmaceuticals in a research report issued to … [+3139 chars]...
Read more